Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review

I Youngster, L Arcavi, R Schechmaster, Y Akayzen… - Drug safety, 2010 - Springer
Abstract Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common
human enzyme defect and one of the most common genetic disorders worldwide, with an …

Shiga toxin producing Escherichia coli

A Bryan, I Youngster… - Clinics in laboratory …, 2015 - labmed.theclinics.com
Enteropathogenic Escherichia coli are commonly classified pathotypically, by the patterns of
manifestations observed in infection (Table 1). However, these descriptively useful terms …

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

EN Baruch, I Youngster, G Ben-Betzalel, R Ortenberg… - Science, 2021 - science.org
The gut microbiome has been shown to influence the response of tumors to anti–PD-1
(programmed cell death–1) immunotherapy in preclinical mouse models and observational …

Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection

I Youngster, GH Russell, C Pindar, T Ziv-Baran, J Sauk… - Jama, 2014 - jamanetwork.com
Importance Fecal microbiota transplantation (FMT) has been shown to be effective in
treating relapsing or refractoryClostridium difficileinfection, but practical barriers and safety …

Fecal Microbiota Transplant for Treatment ofClostridium difficileInfection in Immunocompromised Patients

CR Kelly, C Ihunnah, M Fischer, A Khoruts… - Official journal of the …, 2014 - journals.lww.com
OBJECTIVES: Patients who are immunocompromised (IC) are at increased risk
ofClostridium difficileinfection (CDI), which has increased to epidemic proportions over the …

Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled …

I Youngster, J Sauk, C Pindar, RG Wilson… - Clinical Infectious …, 2014 - academic.oup.com
Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen
Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study | Clinical …

SARS-CoV-2–specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women

SH Perl, A Uzan-Yulzari, H Klainer, L Asiskovich… - Jama, 2021 - jamanetwork.com
Methods| We conducted a prospective cohort study of a convenience sample of
breastfeeding women (either exclusive or partial) belonging to vaccine-target groups who …

Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial

AY Meir, E Rinott, G Tsaban, H Zelicha, A Kaplan… - Gut, 2021 - gut.bmj.com
Objective To examine the effectiveness of green-Mediterranean (MED) diet, further restricted
in red/processed meat, and enriched with green plants and polyphenols on non-alcoholic …

[PDF][PDF] Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation

CS Smillie, J Sauk, D Gevers, J Friedman, J Sung… - Cell host & …, 2018 - cell.com
Fecal microbiota transplantation (FMT) from healthy donor to patient is a treatment for
microbiome-associated diseases. Although the success of FMT requires donor bacteria to …

[HTML][HTML] Ibuprofen use and clinical outcomes in COVID-19 patients

E Rinott, E Kozer, Y Shapira, A Bar-Haim… - Clinical Microbiology and …, 2020 - Elsevier
Objective It was recently suggested that ibuprofen might increase the risk for severe and
fatal coronavirus disease 2019 (COVID-19) and should therefore be avoided in this patient …